Approaches for prevention of restenosis. - Wikidata - awgldk - TriplyDB

Approaches for prevention of restenosis.

Approaches for prevention of restenosis.

http://www.wikidata.org/entity/Q37039843

about

A novel stent coated with antibodies to endoglin inhibits neointimal formation of porcine coronary arteries Amino acid sequence preferences to control cell-specific organization of endothelial cells, smooth muscle cells, and fibroblasts.Scoparone interferes with STAT3-induced proliferation of vascular smooth muscle cells.Therapeutic potential for protein kinase C inhibitor in vascular restenosis.Shear- vs. nanotopography-guided control of growth of endothelial cells on RGD-nanoparticle-nanowell arrays.Diagnostic value of microRNA-143 in predicting in-stent restenosis for patients with lower extremity arterial occlusive disease.Not any new functional polymer can be for medicine: what about artificial biopolymers?Surface chemical and physical modification in stent technology for the treatment of coronary artery disease.Dexamethasone-eluting vascular stents.Renin-angiotensin system inhibitors in patients with coronary artery disease who have undergone percutaneous coronary intervention.Collagen type IV-specific tripeptides for selective adhesion of endothelial and smooth muscle cells.Delivery of viral vectors for gene therapy in intimal hyperplasia and restenosis in atherosclerotic swine.Magnesium used in bioabsorbable stents controls smooth muscle cell proliferation and stimulates endothelial cells in vitro.Cardiovascular stents: overview, evolution, and next generation

P2860

Q33634727-244BD8A8-7B3E-4ABE-BE0B-E92D2FE069FC Q33832534-50BD68F2-197C-412B-81C9-7D8212D6C625 Q35152938-2DF5E4DF-D846-4937-B3FB-B031BEE51BC2 Q36480056-1517C2A3-6C63-4C50-9BAF-8D1334703B1E Q36798121-69AC2D6E-6123-4EDC-91A0-2BA32F657520 Q37566356-6CEE2D8C-F767-4811-9E50-E2EAF868A23A Q37952640-32A3524C-8A2C-4FD7-9C94-79AEF98A45D2 Q38040738-41C29F26-C428-4023-AE76-D1600B1F03FF Q38078557-F72EA7DD-8A66-42A6-93A6-80A29A4F2734 Q38835716-20F1E32A-B536-4F36-BCBC-1FD325B7D693 Q39391749-F4DE6283-EE11-47F9-87E6-4D2461FA8A67 Q39434479-1D1DAA44-97A1-4A09-B4AC-0787D5290287 Q43994933-A0046A01-CB28-4035-AB01-D4CBD5A55A09 Q58752931-6E4C4C92-A14F-49E6-839C-859AA003AAC4

P2860

Approaches for prevention of restenosis.

http://www.wikidata.org/entity/Q37039843

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on May 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Approaches for prevention of restenosis.

@en

Approaches for prevention of restenosis.

@nl

type

label

Approaches for prevention of restenosis.

@en

Approaches for prevention of restenosis.

@nl

prefLabel

Approaches for prevention of restenosis.

@en

Approaches for prevention of restenosis.

@nl

P1433

Q37039843-59C1C2BC-4EDD-4D26-828C-068E645A85D3

P1476

Q37039843-2D526F26-661F-43EC-98BC-7595F539F0E9

P2093

Q37039843-29EF5460-1462-4BF6-878D-0BBC531E43A0

Q37039843-D413A9D5-7193-4BB1-95DD-43FDC0FA468F

Q37039843-EBB760B2-D346-4EEA-95CC-8186F7964CDB

P2860

Q37039843-1438A71A-1E2F-4983-9D07-33662E1BC778

Q37039843-3105C1B3-A578-4789-912F-7B197F184FAC

Q37039843-6D0BEDF2-0BCD-4195-BB9A-BC65FC916028

Q37039843-82A23797-0651-438A-9A55-B8E9B888D93E

Q37039843-B32651BA-F66C-4350-A386-960EE1FF71EF

Q37039843-C47FAFCE-7AAE-4F58-9DE1-BBD6656769D1

Q37039843-D8D2AD87-A201-4407-A1E5-1F8CE064B25A

P304

Q37039843-232FAC69-1EAA-4182-B5D1-6CC11092FA34

P31

Q37039843-AA5F80D7-C010-4028-BD68-85C7ACA3F6DE

P356

Q37039843-81E73F7E-0D7B-449A-B1D8-1755104F5703

P433

Q37039843-7F7881B8-C55F-42F4-9E90-AE7EC52F47C2

P478

Q37039843-55B63EB0-8B64-4A34-948B-5FD1505F70E1

P577

Q37039843-4D811114-3A23-4A91-987F-4FD5E740CEEF

P5875

Q37039843-CD6F0983-66D5-4FF1-8B7C-B0C155FF8506

P698

Q37039843-CB83A467-48EB-4004-BA1E-4FC78AE9A08C

P356

P1433

Journal of Biomedical Materials Research Part B

P1476

Approaches for prevention of restenosis.

@en

P2093

Amir Kraitzer

http://www.w3.org/2001/XMLSchema#string

Meital Zilberman

http://www.w3.org/2001/XMLSchema#string

Yoel Kloog

http://www.w3.org/2001/XMLSchema#string

P2860

Paclitaxel stent coating inhibits neointimal hyperplasia at 4 weeks in a porcine model of coronary restenosis

Drug-eluting stents: potential applications for peripheral arterial occlusive disease.

Inhibition of neointima formation after experimental coronary artery stenting: a new biodegradable stent coating releasing hirudin and the prostacyclin analogue iloprost.

Percutaneous coronary intervention in the current era compared with 1985-1986: the National Heart, Lung, and Blood Institute Registries.

Initial and 6-month results of biodegradable poly-l-lactic acid coronary stents in humans.

Paclitaxel-eluting composite fibers: drug release and tensile mechanical properties.

Paclitaxel-loaded composite fibers: microstructure and emulsion stability.

P304

583-603

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JBM.B.30974

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

85

http://www.w3.org/2001/XMLSchema#string

P577

2008-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5751314

http://www.w3.org/2001/XMLSchema#string

P698

18098192

http://www.w3.org/2001/XMLSchema#string